Idiopathic Pulmonary Fibrosis News and Research

RSS
Pulmonary fibrosi is a condition in which tissue deep in your lungs becomes thick and stiff, or scarred, over time. The development of the scarred tissue is called fibrosis. As the lung tissue becomes thicker, your lungs lose their ability to move oxygen into your bloodstream. As a result, your brain and other organs don't get the oxygen they need.

In some cases, doctors can find out what's causing the fibrosis. But in most cases, they can't find a cause. They call these cases idiopathic pulmonary fibrosis (IPF). IPF is a serious condition. About 200,000 Americans have it. About 50,000 new cases are diagnosed each year. IPF mostly affects people who are 50 to 75 years of age. IPF varies from person to person. In some people, the lung tissue quickly becomes thick and stiff. In others, the process is much slower. In some people, the condition stays the same for years. IPF has no cure yet. Many people live only about 3 to 5 years after diagnosis. The most common cause of death related to IPF is respiratory failure.
Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

U-M study reveals potential pathway to reverse lung fibrosis

U-M study reveals potential pathway to reverse lung fibrosis

Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy

UVA research could help identify COVID-19 survivors at risk for long-haul lung problems

UVA research could help identify COVID-19 survivors at risk for long-haul lung problems

UVA scientists develop new approach to machine learning for identifying heart drug

UVA scientists develop new approach to machine learning for identifying heart drug

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Healthy fats from fish and nuts may slow lung scarring, delay transplants

Healthy fats from fish and nuts may slow lung scarring, delay transplants

Study suggests iron accumulation plays a central role in senescence and fibrosis

Study suggests iron accumulation plays a central role in senescence and fibrosis

Insilico Medicine hosts three webinars to unveil latest technology breakthroughs

Insilico Medicine hosts three webinars to unveil latest technology breakthroughs

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

Insilico Medicine to present scientific data on novel anti-cancer assets at major cancer conferences

New analytical tool could lead to a cure for idiopathic pulmonary fibrosis

New analytical tool could lead to a cure for idiopathic pulmonary fibrosis

Newly identified stem cell variants drive inflammation in cystic fibrosis patients

Newly identified stem cell variants drive inflammation in cystic fibrosis patients

Stem cells can be used to repair damaged lung tissue in COPD patients

Stem cells can be used to repair damaged lung tissue in COPD patients

The standard of care and recent advancements in the control of skin inflammation

The standard of care and recent advancements in the control of skin inflammation

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice

Addressing research gaps: The UK's efforts to study lung cancer in never smokers

Addressing research gaps: The UK's efforts to study lung cancer in never smokers

3D-printed vaginal ovules offer promising treatment for endometriosis

3D-printed vaginal ovules offer promising treatment for endometriosis

Insilico announces new multimodal transformer-based aging clock for processing diverse data sets

Insilico announces new multimodal transformer-based aging clock for processing diverse data sets

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.